These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7688853)

  • 21. A novel cleavage product of beta-thromboglobulin formed in cultures of stimulated mononuclear cells activates human neutrophils.
    Walz A; Baggiolini M
    Biochem Biophys Res Commun; 1989 Mar; 159(3):969-75. PubMed ID: 2522778
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Production of chemokines CTAPIII and NAP/2 by digestion of recombinant ubiquitin-CTAPIII with yeast ubiquitin C-terminal hydrolase and human immunodeficiency virus protease.
    Mildner AM; Paddock DJ; LeCureux LW; Leone JW; Anderson DC; Tomasselli AG; Heinrikson RL
    Protein Expr Purif; 1999 Jul; 16(2):347-54. PubMed ID: 10419831
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of the neutrophil-activating peptide NAP-2, platelet basic protein, connective tissue-activating peptide III and platelet factor 4 on human neutrophils.
    Walz A; Dewald B; von Tscharner V; Baggiolini M
    J Exp Med; 1989 Nov; 170(5):1745-50. PubMed ID: 2681518
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased microvascular permeability in vivo in response to intradermal injection of neutrophil-activating protein (NAP-2) in rabbit skin.
    Van Osselaer N; Van Damme J; Rampart M; Herman AG
    Am J Pathol; 1991 Jan; 138(1):23-7. PubMed ID: 1824807
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The crystal structure of recombinant human neutrophil-activating peptide-2 (M6L) at 1.9-A resolution.
    Malkowski MG; Wu JY; Lazar JB; Johnson PH; Edwards BF
    J Biol Chem; 1995 Mar; 270(13):7077-87. PubMed ID: 7706245
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Formation and biological properties of neutrophil activating peptide 2 (NAP-2).
    Walz A; Zwahlen R; Baggiolini M
    Adv Exp Med Biol; 1991; 305():39-46. PubMed ID: 1755378
    [No Abstract]   [Full Text] [Related]  

  • 27. Isolation, characterization, and immunological detection of neutrophil-activating peptide 2: a proteolytic degradation product of platelet basic protein.
    Holt JC; Yan ZQ; Lu WQ; Stewart GJ; Niewiarowski S
    Proc Soc Exp Biol Med; 1992 Feb; 199(2):171-7. PubMed ID: 1531540
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemotactic activity of human blood leukocytes in plasma treated with EDTA: chemoattraction of neutrophils about monocytes is mediated by the generation of NAP-2.
    Malawista SE; Van Damme J; Smallwood JI; de Boisfleury Chevance A
    J Leukoc Biol; 2002 Jul; 72(1):175-82. PubMed ID: 12101278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High- and low-affinity binding of GRO alpha and neutrophil-activating peptide 2 to interleukin 8 receptors on human neutrophils.
    Schumacher C; Clark-Lewis I; Baggiolini M; Moser B
    Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10542-6. PubMed ID: 1438244
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generation of the neutrophil-activating peptide NAP-2 from platelet basic protein or connective tissue-activating peptide III through monocyte proteases.
    Walz A; Baggiolini M
    J Exp Med; 1990 Feb; 171(2):449-54. PubMed ID: 2406364
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Connective tissue-activating peptide-III and its derivative, neutrophil-activating peptide-2, release histamine from human basophils.
    Reddigari SR; Kuna P; Miragliotta GF; Kornfeld D; Baeza ML; Castor CW; Kaplan AP
    J Allergy Clin Immunol; 1992 Mar; 89(3):666-72. PubMed ID: 1372016
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemical synthesis, purification, and characterization of two inflammatory proteins, neutrophil activating peptide 1 (interleukin-8) and neutrophil activating peptide.
    Clark-Lewis I; Moser B; Walz A; Baggiolini M; Scott GJ; Aebersold R
    Biochemistry; 1991 Mar; 30(12):3128-35. PubMed ID: 2007144
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential effects of neutrophil-activating peptide 1/IL-8 and its homologues on leukocyte adhesion and phagocytosis.
    Detmers PA; Powell DE; Walz A; Clark-Lewis I; Baggiolini M; Cohn ZA
    J Immunol; 1991 Dec; 147(12):4211-7. PubMed ID: 1721641
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Generation of the neutrophil-activating peptide-2 by cathepsin G and cathepsin G-treated human platelets.
    Cohen AB; Stevens MD; Miller EJ; Atkinson MA; Mullenbach G
    Am J Physiol; 1992 Aug; 263(2 Pt 1):L249-56. PubMed ID: 1387511
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neutrophil-activating peptide-2 in patients with pulmonary edema from congestive heart failure or ARDS.
    Cohen AB; Stevens MD; Miller EJ; Atkinson MA; Mullenbach G; Maunder RJ; Martin TR; Wiener-Kronish JP; Matthay MA
    Am J Physiol; 1993 May; 264(5 Pt 1):L490-5. PubMed ID: 8498526
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure and neutrophil-activating properties of a novel inflammatory peptide (ENA-78) with homology to interleukin 8.
    Walz A; Burgener R; Car B; Baggiolini M; Kunkel SL; Strieter RM
    J Exp Med; 1991 Dec; 174(6):1355-62. PubMed ID: 1744577
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Purification of granulocyte chemotactic peptide/interleukin-8 reveals N-terminal sequence heterogeneity similar to that of beta-thromboglobulin.
    Van Damme J; Van Beeumen J; Conings R; Decock B; Billiau A
    Eur J Biochem; 1989 May; 181(2):337-44. PubMed ID: 2523801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Repeated helical epitopes of defined amino acid sequence in human type III collagen identified by monoclonal antibodies.
    Hori H; Keene DR; Sakai LY; Wirtz MK; Bächinger HP; Godfrey M; Hollister DW
    Mol Immunol; 1992 Jun; 29(6):759-70. PubMed ID: 1376414
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The differential ability of IL-8 and neutrophil-activating peptide-2 to induce attenuation of chemotaxis is mediated by their divergent capabilities to phosphorylate CXCR2 (IL-8 receptor B).
    Ben-Baruch A; Grimm M; Bengali K; Evans GA; Chertov O; Wang JM; Howard OM; Mukaida N; Matsushima K; Oppenheim JJ
    J Immunol; 1997 Jun; 158(12):5927-33. PubMed ID: 9190946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cross-linking of human neutrophil surface proteins to iodinated interleukin 8 or neutrophil activating peptide-2 results in at least four separable proteins.
    Besemer J; Schnitzel W; Monschein U; Ryffel B
    Cytokine; 1993 Sep; 5(5):512-9. PubMed ID: 8142608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.